Provide a genomic-based, comprehensive, individualized risk assessment for early-stage cancers in specific settings.
Inform treatment options for those facing the challenges of advanced-stage cancer.
Understand how genomic testing can help to guide your individualized treatment options.
Dr. Jean-Paul De La O discusses real-world case studies demonstrating how whole-exome and whole-transcriptome sequencing has been used to enhance patient care.
You are now leaving this site. Any third party link you select from this site may take you to a website that is not affiliated with Exact Sciences.